It works with your biology by fighting inflammation and supporting the Anagen phase gently
Mechanistically, this combination therapy modulates key mediators such as thromboxane A2 (TXA2) and prostacyclin (PGI2), including their downstream effector cyclooxygenase-2 (COX-2), thereby contributing to its antithrombotic properties
doi: 10.1007/s11055-007-0095-3
This compound appears in research discussions related to copper peptide pathway models, skin matrix pathway research, collagen pathway behavior, extracellular matrix response, peptide-metal complex signaling, cellular response behavior, molecular structure evaluation, and controlled pathway-specific response
These peptides remain investigational
In white adipose tissue, blocking NNMT elevated resting calorie burn, decreased adiposity, and improved insulin sensitivity in rodent models, independent of diet or activity changes (Kraus et al., Nature Medicine )